Pacific Biosciences Of California (PACB) EBITDA Margin (2010 - 2026)
Pacific Biosciences Of California (PACB) posted EBITDA Margin of -108.41% for Q2 2026, down 4.87 percentage points from -103.54% a year earlier and down 94.60 percentage points from the prior quarter.
Pacific Biosciences Of California (PACB) EBITDA Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Pacific Biosciences Of California was -75.50%, up 113.42 percentage points year-over-year; for FY2025, it was -107.13%, up 174.08 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +17.03 percentage points (FY2020 to FY2025).
- In prior years, Pacific Biosciences Of California's EBITDA Margin was -281.21% in FY2024 (-124.26 pp), -156.94% in FY2023 (+74.37 pp), -231.31% in FY2022 (-75.59 pp) and -155.72% in FY2021 (-31.56 pp).
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +77.42 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2025, with a gain of 356.00 percentage points; the weakest was Q2 2024, with a drop of 312.16 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -13.82% (Q1 2026), -83.84% (Q4 2025) and -92.08% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | Pacific Biosciences Of California | 531.49 Mn | -559.51 Mn | 12.64 Mn | -108.41% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -108.41% |
| Mar 31, 2026 | -13.82% |
| Dec 31, 2025 | -83.84% |
| Sep 30, 2025 | -92.08% |
| Jun 30, 2025 | -103.54% |
| Mar 31, 2025 | -154.53% |
| Dec 31, 2024 | -365.35% |
| Sep 30, 2024 | -132.69% |
| Jun 30, 2024 | -459.54% |
| Mar 31, 2024 | -183.64% |
| Dec 31, 2023 | -133.12% |
| Sep 30, 2023 | -141.22% |
| Jun 30, 2023 | -147.38% |
| Mar 31, 2023 | -226.90% |
| Dec 31, 2022 | -308.17% |
| Sep 30, 2022 | -222.97% |
| Jun 30, 2022 | -184.45% |
| Mar 31, 2022 | -226.17% |
| Dec 31, 2021 | -173.29% |
| Sep 30, 2021 | -208.48% |
Pacific Biosciences Of California EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PACB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PACB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PACB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();